The Study of ICP-248 in Patients With Mature B-cell Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Study of ICP-248 in Patients With Mature B-cell Malignancies	Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm	Recruiting	Phase 1	2025-09-08		NCT05728658

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing InnoCare Pharma Tech Co., Ltd.	26

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fujian Medical University Union Hospital	Fuzhou	China	107
Hematology Hospital, Chinese Academy of Medical Sciences	Tianjin	China	1
Henan Cancer Hospital	Zhengzhou	China	67
Hunan Cancer Hospital	Changsha	China	41
Jiangsu Province Hospital	Nanjing	China	89
Jiangxi Cancer Hospital	Nanchang	China	48
Peking University Third Hospital	Beijing	China	123
Ruijin Hospital, Shanghai Jiaotong University School of Medicine	Shanghai	China	45
Shandong Cancer Hospital	Jinan	China	86
Shenyang Hospital Of China Medical University	Shenyang	China	1
Sun Yat-sen University Cancer Center	Guangzhou	China	7
The Central Hospital of Wuhan	Wuhan	China	9
The First affiliated Hospital of Anhui Medical University	Hefei	China	56
The First Affiliated Hospital of Bengbu Medical College	Bengbu	China	6
The First Affiliated Hospital of Chongqing Medical University	Chongqing	China	70
The First Affiliated Hospital of Nanchang University	Nanchang	China	18
The First Affiliated hospital of Xiamen University	Xiamen	China	69
The First Affiliated Hospital of Zhejiang University School of Medicine	Hangzhou	China	12
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	3
The Second Hospital of Dalian Medical University	Dalian	China	8
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	77
West China Hospital of Sichuan University	Chengdu	China	23

Clinical trials